These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1625412)

  • 1. [Circulatory insufficiency, ischemic disease, arrhythmia and the renin-angiotensin-aldosterone system and angiotensin converting enzyme inhibitors].
    Gebalska J
    Kardiol Pol; 1992 May; 36(5):301-5. PubMed ID: 1625412
    [No Abstract]   [Full Text] [Related]  

  • 2. [Angiotensin-converting enzyme inhibitors and ischemic heart disease].
    Ertl G; Kochsiek K
    Dtsch Med Wochenschr; 1989 Apr; 114(14):556-60. PubMed ID: 2649347
    [No Abstract]   [Full Text] [Related]  

  • 3. [The coronary circulation, renin-angiotensin system and ACE inhibition].
    Campa PP
    Cardiologia; 1995 Sep; 40(9):635-41. PubMed ID: 8542615
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias.
    Garg S; Narula J; Marelli C; Cesario D
    Am J Cardiol; 2006 Mar; 97(6):921-5. PubMed ID: 16516603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking the renin-angiotensin-aldosterone system or lowering the blood pressure: does EUROPA help?
    Mackay JA
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):205-6. PubMed ID: 14689366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the renin-angiotensin system. Effect on mortality in patients with left ventricular systolic dysfunction.
    Pitt B
    Cardiol Clin; 1994 Feb; 12(1):101-14. PubMed ID: 8181019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin-aldosterone system: approaches to guide angiotensin-converting enzyme inhibition in patients with coronary artery disease.
    Brugts JJ; den Uil CA; Danser AH; Boersma E
    Cardiology; 2009; 112(4):303-12. PubMed ID: 18832826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibition and vascular remodeling in coronary artery disease.
    Adams KF
    Coron Artery Dis; 1998; 9(10):675-84. PubMed ID: 9894619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological interference with the cardiac renin-angiotensin system.
    Becker RH; Linz W; Schölkens BA
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S10-5. PubMed ID: 2483422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors.
    Weinberg MS; Weinberg AJ; Zappe DH
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):217-33. PubMed ID: 11881029
    [No Abstract]   [Full Text] [Related]  

  • 12. [Angiotensin converting enzyme inhibitors in ischemic heart disease].
    Takác M; Koval S; Takác V; Takác P
    Vnitr Lek; 1996 Apr; 42(4):290-6. PubMed ID: 8693718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the renin-angiotensin-aldosterone system in elderly patients with chronic ischemic heart disease. 4. The renin-angiotensin-aldosterone system in elderly patients with ischemic heart disease and cardiovascular insufficiency].
    Korkusko OV; Kalinovskaja EG; Fedirko MI; Gidzinskaja IN
    Z Alternsforsch; 1989; 44(3):149-54. PubMed ID: 2669367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [AT1 angiotensin receptor inhibition as a new therapeutic possibility].
    Hunyady L; Nagy L
    Orv Hetil; 1997 Oct; 138(41):2583-90. PubMed ID: 9411327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of hyperbaric oxygenation on the status of the renin-angiotensin-aldosterone system in chronic circulatory insufficiency in elderly patients with ischemic heart disease].
    Khaĭdarova GKh; Borukhova ES; Asinova MI
    Anesteziol Reanimatol; 1989; (3):33-5. PubMed ID: 2802239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of converting enzyme inhibitor angiotensin I to angiotensin II in treatment of patients with coronary disease].
    Halawa B
    Pol Merkur Lekarski; 1998 Jan; 4(19):32-4. PubMed ID: 9553407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence and implications of aldosterone breakthrough.
    Bomback AS; Klemmer PJ
    Nat Clin Pract Nephrol; 2007 Sep; 3(9):486-92. PubMed ID: 17717561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the renin-angiotensin-aldosterone system to prevent ischemic and atherothrombotic events.
    Papademetriou V
    Am Heart J; 2009 Jun; 157(6 Suppl):S24-30. PubMed ID: 19450721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic prospects of renin-angiotensin system inhibition.
    Corvol P
    Clin Exp Hypertens A; 1989; 11 Suppl 2():463-70. PubMed ID: 2691125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.